Myriad Genetics Announces Proposed Offering of $100 Million

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing...

Related Keywords

New York ,United States ,Glenn Farrell ,Matt Scalo ,Company Quarterly Reports On Form ,Exchange Commission ,Morgan Stanley ,Company Or Myriad Genetics ,Company Annual Report On Form ,Genetics Inc ,Wells Fargo Securities ,Prospectus Department ,Goldman Sachs Co ,Nasdaq ,Myriad Genetics ,Securities Litigation ,Goldman Sachs ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Nasdaq Mygn ,Nc ,